The initial investigations of TDP-43 in the CSF as a biomarker for ALS used the same anti-TDP-43 antibody recognizing the NTD, showing a significant increase of total TDP-43 concentration [60]. This evidence concerns the gene TARDBP and amyotrophic lateral sclerosis.